Sophia Antipolis - 23 April 2021: A study of 2.4 million hospitalised cannabis users has found that those with an arrhythmia were 4.5 times more likely to die while in hospital than those without. The research is presented at EHRA 2021, an online scientific congress of the European Society of Cardiology (ESC).1
"People should be aware of this devastating outcome and be careful when using cannabis if they have a concomitant heart problem," said study author Dr. Sittinun Thangjui of Bassett Healthcare Network, Cooperstown, US.
Marijuana or cannabis is the most commonly used psychoactive substance worldwide.2 However, there is limited knowledge about safety of the drug in people with cardiac arrhythmias. This study examined the burden of arrhythmias in drug users admitted to hospital. It also compared length of hospital stay and deaths in hospital between those with and without an arrhythmia.
The study was conducted using the National Inpatient Sample database, which covers 97% of the US population. The study included 2,457,544 adult cannabis users admitted to hospital in 2016 to 2018. Of those, 187,825 (7.6%) patients had an arrhythmia. Atrial fibrillation was the most common, followed by abnormally slow heart rate and abnormally fast heart rate.
Patients in arrhythmia group were older: the average age was 50.5 years compared to 38.3 years for those without an arrhythmia. Those with arrhythmias also had more co-existing health conditions.
The researchers compared deaths between the two groups after adjusting for factors that could influence the relationship including age, sex, race, income, diabetes, heart failure, chronic kidney disease, obesity, and hospital location. Cannabis users with an arrhythmia had a 4.5 times higher odds of in-hospital mortality compared to those without an arrhythmia. Patients with an arrhythmia had a longer length of hospital stay (5.7 days) compared to those without (5.1 days).
Dr. Thangjui said: "Our study highlights that heart rhythm disorders may be a warning sign for an increased risk of death in people who use cannabis. More studies are needed to confirm our results. In the meantime, it seems sensible to screen these patients for arrhythmias if they present to hospital so that those with a heart rhythm problem can be closely monitored."
###
Authors: ESC Press Office
Tel: +33 (0)4 89 87 20 85
Mobile: +33 (0)7 8531 2036
Email: press@escardio.org
Follow us on Twitter @ESCardioNews
Notes to editor
Funding: None.
Disclosures: None.
References and notes
1Abstract title: Burden of arrhythmia in hospitalized patients with cannabis use related disorders: analysis of 2016-2018 national inpatient sample.
2United Nations Office on Drugs and Crime. World Drug Report 2018.
About the European Heart Rhythm Association
The European Heart Rhythm Association (EHRA) is a branch of the European Society of Cardiology (ESC). Its aim is to improve patients' quality of life and reduce sudden cardiac death by limiting the impact of heart rhythm disturbances.
About the EHRA Congress #EHRA2021
EHRA 2021 is the online annual congress of the European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC).
About the European Society of Cardiology
The European Society of Cardiology brings together health care professionals from more than 150 countries, working to advance cardiovascular medicine and help people lead longer, healthier lives.
Information for journalists about registration for EHRA 2021
EHRA 2021 takes place 23 to 25 April online.
- Free registration applies only to accredited press.
- Credentials: A valid press card or appropriate letter of assignment with proof of three recent published articles (cardiology or health-related or referring to a previous ESC event). Read the ESC media and embargo policy.
- The ESC Press Office will verify the documents and confirm by email that your press accreditation is valid.
- The ESC Press Office decision is final regarding all press registration requests.